Plain-English translation of NCT04366804 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →Researchers are testing two new questionnaires — one to measure emotional and mood changes that come and go with medication (called the Neuropsychiatric Fluctuations Scale), and another to measure feelings of shame or embarrassment related to Parkinson's disease (called the Shame in Parkinson's Disease Scale). These questionnaires are being validated across six European countries to see if they reliably capture symptoms that current rating tools miss.
People with Parkinson's disease often experience emotional and psychological symptoms that doctors don't always recognize or ask about — like shame about losing independence, embarrassment about body changes, or mood swings linked to when medications wear off. Creating better tools to measure these hidden symptoms will help doctors understand how Parkinson's truly affects quality of life and provide better support.
You likely qualify if…
You likely don't qualify if…
You will complete two new questionnaires — one with 20 questions about mood and emotional changes, and another with 25 questions about feelings of shame or embarrassment related to your Parkinson's. The study takes place at hospitals and clinics in Spain, Germany, France, Switzerland, Romania, and Greece. Researchers will compare answers between people who experience emotional fluctuations with medication and those who don't, to confirm the questionnaires work accurately.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France
Germany
Greece
Romania
Spain